TAGS "AstraZeneca"
All News AstraZeneca In Focus AstraZeneca BreakingNews of AstraZeneca Your Interested Follow Story AstraZeneca
AstraZeneca and Siriraj Genomics join forces for the third annual Rethink Pink We Care Event: Empowering Thai women against breast cancer
AstraZeneca and Siriraj Genomics join forces for the third annual Rethink Pink We Care Event: Empowering Thai women against breast cancer
THURSDAY, OCTOBER 31, 2024
Bangkok – AstraZeneca Thailand, in collaboration with the Siriraj Genomics Center at the Faculty of Medicine Siriraj Hospital and esteemed partners, announces the continuation of the “Rethink Pink We Care” event for the third consecutive year.AstraZeneca commits to collaborating with Thai government on tackling NCDs
AstraZeneca commits to collaborating with Thai government on tackling NCDs
FRIDAY, JUNE 14, 2024
AstraZeneca has announced a three-year investment and partnership plan after meeting with Prime Minister Srettha Thavisin on June 12, 2024, in Bangkok. The plan aligns with the government's vision to make Thailand a wellness and medical hub.BNH Hospital, AstraZeneca to collaborate on asthma care
BNH Hospital, AstraZeneca to collaborate on asthma care
WEDNESDAY, MAY 15, 2024
Bangkok-based BNH Hospital and biopharmaceutical company AstraZeneca (Thailand) signed a collaborative framework aimed at establishing a network for comprehensive asthma care on Wednesday.AstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
AstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
WEDNESDAY, MAY 08, 2024
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its Covid-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.Thailand no longer using AstraZeneca's Covid-19 vaccines
Thailand no longer using AstraZeneca's Covid-19 vaccines
WEDNESDAY, MAY 01, 2024
The Ministry of Public Health says it has known about the risk of blood-clotting side effects from AstraZeneca’s Covid-19 vaccine since the beginning, and confirmed it has not purchased additional AstraZeneca vaccines after stocks were depleted.Introducing Asthma Smart Kiosk for Lung Disease Management
Introducing Asthma Smart Kiosk for Lung Disease Management
FRIDAY, MARCH 29, 2024
AstraZeneca (Thailand) Co., Ltd. has partnered with Buddhachinnaraj Hospital in Phitsanulok Province through a strategic collaboration to install the Asthma Smart Kiosk.AstraZeneca Thailand partners with BMA to enhance early-stage lung cancer diagnosis
AstraZeneca Thailand partners with BMA to enhance early-stage lung cancer diagnosis
FRIDAY, OCTOBER 13, 2023
AstraZeneca (Thailand) and the Bangkok Metropolitan Administration (BMA) recently signed a memorandum of understanding (MoU) under the “Don't Wait. Get Checked” project to enhance early-stage incidental lung cancer screening in Bangkok by leveraging AI technology.AstraZeneca Thailand announces partnership with Phyathai 2 Hospital Introduces AI to enhance the diagnosis of early-stage lung cancer
AstraZeneca Thailand announces partnership with Phyathai 2 Hospital Introduces AI to enhance the diagnosis of early-stage lung cancer
TUESDAY, MARCH 21, 2023
Bangkok – AstraZeneca (Thailand) Company Limited has signed a Memorandum of Understanding (MoU) with Phyathai 2 Hospital to use AI-based technology for chest X-rays in the hospital.AstraZeneca vaccine highly effective at preventing COVID-19 severe outcomes and death when used as first or second booster: study
AstraZeneca vaccine highly effective at preventing COVID-19 severe outcomes and death when used as first or second booster: study
TUESDAY, DECEMBER 13, 2022
WHO recommends COVID-19 Vaccine AstraZeneca as booster in revised Good Practice Statement on the use of COVID-19 Boosters, based on latest dataCOVID-19 vaccines continue to protect against death and hospitalization worldwide while boosters can help top up immunity for vulnerable
COVID-19 vaccines continue to protect against death and hospitalization worldwide while boosters can help top up immunity for vulnerable
FRIDAY, SEPTEMBER 30, 2022
Special interview with Professor Sir Andrew J. Pollard, FMedSci, Director of Oxford Vaccine Group and Professor of Paediatric Infection and Immunity, Department of Paediatrics, University of Oxford